Melianthe P J Nicolai

Dr. Melianthe P J Nicolai

orcid

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 February 2013 in Clinical Research in Cardiology
Verified
Journal Article
Closed access
PDF file
MNMelianthe P J Nicolai
Melianthe P J Nicolai
SBS. Both
S. Both
SLS. S. Liem
S. S. Liem
RPR. C. M. Pelger
R. C. M. Pelger
HPH. Putter
H. Putter
HEH. W. Elzevier
H. W. Elzevier

15 September 2011 in The Journal of Immunology
Verified
Journal Article
Open access
PDF file
JDJames W. Dear
James W. Dear
KSKenneth J. Simpson
Kenneth J. Simpson
MNMelianthe P J Nicolai
Melianthe P J Nicolai
JCJames H. Catterson
James H. Catterson
JSJonathan Street
Jonathan Street
DWDavid J. Webb
David J. Webb
The immune system is alerted to cell death by molecules known as damage-associated molecular patterns (DAMPs). These molecules partly mediate acetaminophen-induced liver injury, an archetypal experimental model of sterile cell death and the commonest cause of acute liver failure in the western world. Cyclophilin A (CypA) is an intracellular protein that is proinflammatory when released by cells. We hypothesized that CypA is released from necrotic liver cells and acts as a DAMP to mediate acetaminophen-induced liver injury. Our data demonstrated that mice lacking CypA (Ppia−/−) were resistant to acetaminophen toxicity. Antagonism of the extracellular receptor for CypA (CD147) also reduced acetaminophen-induced liver injury. When injected into a wild-type mouse, necrotic liver from Ppia−/− mice induced less of an inflammatory response than did wild-type liver. Conversely, the host inflammatory response was increased when CypA was injected with necrotic liver. Antagonism of CD147 also reduced the inflammatory response to necrotic liver. In humans, urinary CypA concentration was significantly increased in patients with acetaminophen-induced liver injury. In summary, CypA is a DAMP that mediates acetaminophen poisoning. This mechanistic insight presents an opportunity for a new therapeutic approach to a disease that currently has inadequate treatment options.

24 October 2013 in Netherlands Heart Journal
Verified
Journal Article
Open access
PDF file
MNMelianthe P J Nicolai
Melianthe P J Nicolai
SLS. S. Liem
S. S. Liem
SBS. Both
S. Both
RPR. C. M. Pelger
R. C. M. Pelger
HPH. Putter
H. Putter
HEH. W. Elzevier
H. W. Elzevier
Several antihypertensive drugs, such as diuretics and β-blockers, can negatively affect sexual function, leading to diminished quality of life and often to noncompliance with the therapy. Other drug classes, however, such as angiotensin II receptor blockers (ARBs) are able to improve patients’ sexual function. Sufficient knowledge about the effects of these widely used antihypertensive drugs will make it possible for cardiologists and general practitioners to spare and even improve patients’ sexual health by switching to different classes of cardiac medication. Nevertheless, previous data (part I) indicate that most cardiologists lack knowledge about the effects cardiovascular agents can have on sexual function and will thus not be able to provide the necessary holistic patient care with regard to prescribing these drugs. To be able to improve healthcare on this point, we aimed to provide a practical overview, for use by cardiologists as well as other healthcare professionals, dealing with sexual dysfunction in their clinical practices. Therefore, a systematic review of the literature was performed. The eight most widely used classes of antihypertensive drugs have been categorised in a clear table, marking whether they have a positive, negative or no effect on sexual function.

30 June 2015 in European Journal of Surgical Oncology
Verified
Journal Article
Open access
PDF file
EKEsmée M. Krouwel
Esmée M. Krouwel
JHJ.H. Hagen
J.H. Hagen
MNMelianthe P J Nicolai
Melianthe P J Nicolai
AVAlexander Vahrmeijer
Alexander Vahrmeijer
HPH. Putter
H. Putter
HEH.W. Elzevier
H.W. Elzevier
Sexual function is an important factor in quality of life, but at risk after several surgical cancer treatments. Our aim was to identify the practice, responsibility, attitudes, knowledge and barriers of surgical oncologists towards providing informed consent on sexual side effects and sexual counselling. A 31-item questionnaire was sent to all 437 members of the Dutch Society for Surgical Oncology (NVCO). The majority of 165 responding surgical oncologists (85.5%) stated that discussing sexual function is their responsibility, 13.0% thought it to be somebody else's responsibility. During informed consent of a planned surgical procedure, sexual side effects are mentioned by 36.6% of surgeons in more than half of the cases. Counselling sexual function was performed by 9.2% of the surgeons in more than half of the cases. Older surgeons (≥46 y) and male surgeons discuss sexual concerns more often (p = 0.006 v p = 0.045). Barriers most mentioned included advanced age of the patient (50.6%), not relevant for all types of cancers (43.8%), lack of time (39.9%) and no angle or motive for asking (35.2%). Additional training on counselling patients for sexual concerns was required according to 46.3%. Surgical oncologists do not routinely discuss sexual concerns. Informed consent includes limited information about possible complications on sexual function. Surgeons consider themselves responsible for raising the issue of sexual dysfunction, but consider advanced age of patients, lack of time and no angle or motive for asking as major barriers. Results emphasize the need for raising awareness and providing practical training.

2 March 2021 in Frontiers in Surgery
Verified
Journal Article
Open access
PDF file
MNMelianthe P J Nicolai
Melianthe P J Nicolai
AUAhmet Urkmez
Ahmet Urkmez
SSSelcuk Sarikaya
Selcuk Sarikaya
MFMikkel Fode
Mikkel Fode
MFMarco Falcone
Marco Falcone
GRGiorgio Ivan Russo
Giorgio Ivan Russo
After radical prostatectomy (RP) or radiotherapy (RT) for prostate cancer, erectile dysfunction (ED) is the main complication next to urinary incontinence, affecting quality of life. The pathophysiology of ED after these treatments is believed to include neuropraxia causing reduced oxygenation and structural changes of the tissue in the corpora cavernosa. Next to the option of sparing the nerves during RP, research has been focusing on methods for penile rehabilitation after RP and RT, since it occurs often, even after nerve-sparing techniques were used. In animal studies, the use of phosphodiesterase type 5 inhibitors (PDE5i) after cavernous nerve damage is supported, but results in human studies are contradictory. Non-medical treatment options such as vacuum device therapy, hyperbaric oxygen therapy, yoga, aerobic, or pelvic floor training may be helpful, but evidence is scarce. Clear guidelines for penile rehabilitation are not yet available. However, care and support for ED after RP and RT is highly demanded by a large group of patients, so measures have to be taken even though the evidence is not strong yet. In this systematic review, an overview of the literature for penile rehabilitation and treatment options for ED after RP and RT is provided, using only randomized controlled trials (RCT).

1 February 2014 in American Heart Journal
Verified
Journal Article
Closed access
MNMelianthe P J Nicolai
Melianthe P J Nicolai
JBJoyce van Bavel
Joyce van Bavel
GSG. Aernout Somsen
G. Aernout Somsen
GGGreetje J. de Grooth
Greetje J. de Grooth
ITIgor I. Tulevski
Igor I. Tulevski
HEHenk W. Elzevier
Henk W. Elzevier